CA2619605A1 — Inhalation therapy device comprising an ampoule for storing a medicament to be nebulised
Assigned to PARI Pharma GmbH · Expires 2007-02-22 · 19y expired
What this patent protects
The invention relates to an inhalation therapy device (1) which comprises an atomizer (2) for atomizing a drug which is advantageously present in the form of a fluid (8) into an atomization chamber (12) so that an aerosol or mist (21) is provided in the atomization chamber (12). …
USPTO Abstract
The invention relates to an inhalation therapy device (1) which comprises an atomizer (2) for atomizing a drug which is advantageously present in the form of a fluid (8) into an atomization chamber (12) so that an aerosol or mist (21) is provided in the atomization chamber (12). The patient or user can inhale the aerosol (21) produced by the atomizer (2) from the atomization chamber (12) via a mouthpiece (13). The ampoule (100) is inserted into an ampoule holder (3) holding the fluid-containing ampoule (100). The inhalation therapy device (1) also comprises an opening unit (4) for opening the fluid-containing ampoule (100). The ampoule holder (3) advantageously comprises a first part (31), disposed displaceably in relation to the opening unit (4), thereby allowing an ampoule (100) present in the ampoule holder to be displaced in the direction of the opening unit.
Drugs covered by this patent
- glycopyrrolate (Glycopyrrolate) · Yonsei University
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.